Impact of Folinic Acid Dosing on Efficacy and Toxicity of High-Dose Methotrexate in Central Nervous System Lymphoma

Arnon Haran*, Noa Gross Even-Zohar, Michal Haran, Eyal Lebel, Shlomzion Aumann, Adir Shaulov, Moshe Gatt, Boaz Nachmias

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: High-dose methotrexate (HDMTX)-based regimens are the treatment of choice in primary central nervous system lymphoma (PCNSL). Folinic acid (FA) rescue is used to mitigate the toxic effects of MTX on normal cells. However, the optimal dosing of FA in PCNSL remains uncertain. Methods: We analyzed the relationship between FA dosing and treatment efficacy and toxicity in a cohort of 36 PCNSL patients treated at our institute between the years 2014 and 2022. A combination of univariate and multivariate analyses using known prognostic factors were used to determine the association between FA dosing and treatment outcomes. Results: We found that higher per-treatment cumulative FA doses were associated with inferior progression-free survival (PFS), with a hazard ratio (HR) of 2.2 for each 100 mg/m2 increase in FA dose. We identified a threshold of 350 mg/m2/treatment, above which there was a significant reduction in PFS. Notably, lower FA doses did not result in increased toxicity. Conclusion: Our findings suggest that optimizing FA dosing to avoid very high rescue doses may improve treatment outcomes in PCNSL patients receiving HDMTX. Further prospective studies are warranted to validate these findings.

Original languageAmerican English
JournalClinical Lymphoma, Myeloma and Leukemia
Early online date31 Oct 2023
DOIs
StatePublished - Mar 2024

Bibliographical note

Publisher Copyright:
© 2023 Elsevier Inc.

Keywords

  • CNS lymphoma
  • Progression-free survival
  • Retrospective

Fingerprint

Dive into the research topics of 'Impact of Folinic Acid Dosing on Efficacy and Toxicity of High-Dose Methotrexate in Central Nervous System Lymphoma'. Together they form a unique fingerprint.

Cite this